| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |